On December 10, 2020 a
Exhibit,Appendix
was filed
involving a dispute between
Patsy Young,
and
Aventis Inc.,
Avon Products, Inc.,
Block Drug Company, Inc.,
Block Drug Corporation,
Brenntag North America, Inc.,
Brenntag Specialties, Inc. F K A Mineral Pigment Solutions, Inc.,
Charles B. Chrystal Company, Inc.,
Chattem, Inc.,
Colgate-Palmolive Company,
Cyprus Amax Minerals Company,
Cyprus Mines Corporation,
Glaxosmithkline Llc (Sued Individually And As Successor-In-Interest To Block Drug Corporation, Successor-In-Interest To The Gold Bond Sterilizing Powder Company A K A The Gold Bond Company And As A Successor-In-Interest To Novartis Corporation And
Novartis Consumer Health Inc.),
Gsk Consumer Health, Inc. F K A Novartis Consumer Health Inc. F K A Ciba Self-Medication, Inc.,
Insight Pharmaceuticals Corporation, A Subsidiary Of Prestige Brands Holdings, Inc.,
Insight Pharmaceuticals Llc,
Macy'S Inc. F K A Federated Department Stores, Inc.,
Novartis Pharmaceuticals Corporation,
Prestige Brands Holdings, Inc.,
Prestige Consumer Healthcare Inc. F K A Prestige Brands, Inc.,
Sanofi-Aventis U.S. Llc,
Sanofi Us Services, Inc.,
Whittaker Clark & Daniels, Inc.,
for Torts - Asbestos
in the District Court of Erie County.
Preview
FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020
NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023
EXHIBIT 144
FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020
NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023
MASTER EXHIBIT 61
• •
FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020
NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023
The Cosmetic, Toiletry and Fragrance Association, Inc.
1133 15th STREET. N.W., WASHINGTON, D.C. 20005 • 202/331-1770 • TELEX 89-2673 James H. Merritt
Pre•illenl
Norman F. Estrin. Ph.D.
Vice Presidetii~Science
E. Edward Kavanaugh
Vice President-
Congressional Fletations
M I N U T E S Margaret W. Smith
Executive Secretary
CTFA TECHNICAL ADMINISTRATION COMMITTEE
A meeting of the . CTFA Technical Administration Committee was held
on February 1, 1977 at the Old Towne Holiday Inn in Alex~ndria,
Virginia. Members of the Committee present were:
Robert Giovacchini, The Gillette Company
Murray Berdick, Chesebrough-Pond's Inc~
Eustace Fotiu, Revlon, Inc.
Yale Gressel, Avon Products, Inc.
John Menkart, Clairol Inc.
James Rodgers, The Mennen·company (Guest)
Charles Rowland, Avon Products, Inc.
Maurice Siegel, Faberge, Inc.
Norman Estrin, CTFA
James Merritt, CTFA
James McNerney, CTFA
In addition, the following guests from the FDA were:
James Akerson
Henry Davis
Heinz Eiermann
Hyman Gittes
Sidney Green
Martin Greif
A.C. Kolbye
John Lucas
Frank Marzulli
Robert Schaffner
Robert Scheuplein
John Wenninger
Dr. Giovacchini opened the meeting and had the participants
introduce themselves. Dr. Giovacchini, in his opening remarks,
stressed the importance in maintaining a dialogue among scientists
on scientific issues to promote. mutual respect for points of
view. He then proceeded with the agenda.
JNJNL61_000020392
• •
FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020
NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023
- 4 -
prepared explaining to consumers the state of research.
Dr. Menkart agreed this was a good suggestion and will study
the matter further. It was agreed the dialogue in this
area must continue.
4. Talc -~ Dr. Estrin reported publication of a new CTFA
Standard for talc and distributed copies to FDA. He described
a round-robin test of cosmetic tales which have been recently
purchased on the open market. Participants in the round-robin
test include scientists from Mt. Sinai Hospital and the Food
and Drug Administration. Mr. Henry Davis reported on FDA's
work on methodology and described the comparison between the
CTFA method·and FDA's method as follows:
CTFA FDA
1. Analysis Qualitative Quantitative
2. Sensitivity 0.5 0.1
3. Tremolite
Standard CTFA Korean/CTFA
4. Slits
A. Divergence 1% 0 •.5%
B. Receiving 0.2mm. 0.3mm.
s. Mixing Spex Mixer Manual
Mill
6. Equipment Phillips Electronic
APD-3500
Dr. Estrin noted that FDA had been invited to participate at
meetings CTFA has with the Mt. Sinai group and noted the
desirability .of FDA participation in the future. Dr. Marzulli
reported on papers showing cancer from glass fibers and
suggested that possibly shape was more important than the
type of particle. Dr. Giovacchini responded the work referred
to was not new in the scientific literature. Mr. Wenninger
updated the Committee briefly on the National Bureau of
Standards work on talc exposures.
5. Aerosols -- Dr. Gressel described the propellant program
undertaken by the Inter-Industry Aerosol Safety Committee and
current work by a Hydrocarbon Subcommittee which is combining
JNJNL61_000020393
Document Filed Date
March 17, 2023
Case Filing Date
December 10, 2020
Category
Torts - Asbestos
For full print and download access, please subscribe at https://www.trellis.law/.
Preview
FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023 EXHIBIT 144 FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023 MASTER EXHIBIT 61 • • FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023 The Cosmetic, Toiletry and Fragrance Association, Inc. 1133 15th STREET. N.W., WASHINGTON, D.C. 20005 • 202/331-1770 • TELEX 89-2673 James H. Merritt Pre•illenl Norman F. Estrin. Ph.D. Vice Presidetii~Science E. Edward Kavanaugh Vice President- Congressional Fletations M I N U T E S Margaret W. Smith Executive Secretary CTFA TECHNICAL ADMINISTRATION COMMITTEE A meeting of the . CTFA Technical Administration Committee was held on February 1, 1977 at the Old Towne Holiday Inn in Alex~ndria, Virginia. Members of the Committee present were: Robert Giovacchini, The Gillette Company Murray Berdick, Chesebrough-Pond's Inc~ Eustace Fotiu, Revlon, Inc. Yale Gressel, Avon Products, Inc. John Menkart, Clairol Inc. James Rodgers, The Mennen·company (Guest) Charles Rowland, Avon Products, Inc. Maurice Siegel, Faberge, Inc. Norman Estrin, CTFA James Merritt, CTFA James McNerney, CTFA In addition, the following guests from the FDA were: James Akerson Henry Davis Heinz Eiermann Hyman Gittes Sidney Green Martin Greif A.C. Kolbye John Lucas Frank Marzulli Robert Schaffner Robert Scheuplein John Wenninger Dr. Giovacchini opened the meeting and had the participants introduce themselves. Dr. Giovacchini, in his opening remarks, stressed the importance in maintaining a dialogue among scientists on scientific issues to promote. mutual respect for points of view. He then proceeded with the agenda. JNJNL61_000020392 • • FILED: ERIE COUNTY CLERK 03/17/2023 09:21 PM INDEX NO. 815818/2020 NYSCEF DOC. NO. 355 RECEIVED NYSCEF: 03/17/2023 - 4 - prepared explaining to consumers the state of research. Dr. Menkart agreed this was a good suggestion and will study the matter further. It was agreed the dialogue in this area must continue. 4. Talc -~ Dr. Estrin reported publication of a new CTFA Standard for talc and distributed copies to FDA. He described a round-robin test of cosmetic tales which have been recently purchased on the open market. Participants in the round-robin test include scientists from Mt. Sinai Hospital and the Food and Drug Administration. Mr. Henry Davis reported on FDA's work on methodology and described the comparison between the CTFA method·and FDA's method as follows: CTFA FDA 1. Analysis Qualitative Quantitative 2. Sensitivity 0.5 0.1 3. Tremolite Standard CTFA Korean/CTFA 4. Slits A. Divergence 1% 0 •.5% B. Receiving 0.2mm. 0.3mm. s. Mixing Spex Mixer Manual Mill 6. Equipment Phillips Electronic APD-3500 Dr. Estrin noted that FDA had been invited to participate at meetings CTFA has with the Mt. Sinai group and noted the desirability .of FDA participation in the future. Dr. Marzulli reported on papers showing cancer from glass fibers and suggested that possibly shape was more important than the type of particle. Dr. Giovacchini responded the work referred to was not new in the scientific literature. Mr. Wenninger updated the Committee briefly on the National Bureau of Standards work on talc exposures. 5. Aerosols -- Dr. Gressel described the propellant program undertaken by the Inter-Industry Aerosol Safety Committee and current work by a Hydrocarbon Subcommittee which is combining JNJNL61_000020393